OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dihydroartemisinin inhibits Lewis Lung carcinoma progression by inducing macrophages M1 polarization via AKT/mTOR pathway
Xiaoqian Xiao, Yanping Li, Yi Wang, et al.
International Immunopharmacology (2021) Vol. 103, pp. 108427-108427
Closed Access | Times Cited: 23
Xiaoqian Xiao, Yanping Li, Yi Wang, et al.
International Immunopharmacology (2021) Vol. 103, pp. 108427-108427
Closed Access | Times Cited: 23
Showing 23 citing articles:
Traditional Chinese Medicine for Cancer Treatment
Yangli Liu, Fang Cheng, Jiaojiao Luo, et al.
The American Journal of Chinese Medicine (2024) Vol. 52, Iss. 03, pp. 583-604
Closed Access | Times Cited: 16
Yangli Liu, Fang Cheng, Jiaojiao Luo, et al.
The American Journal of Chinese Medicine (2024) Vol. 52, Iss. 03, pp. 583-604
Closed Access | Times Cited: 16
Role of the AKT signaling pathway in regulating tumor-associated macrophage polarization and in the tumor microenvironment: A review
Cong Liang, Song Wang, Chengwei Wu, et al.
Medicine (2025) Vol. 104, Iss. 5, pp. e41379-e41379
Open Access | Times Cited: 2
Cong Liang, Song Wang, Chengwei Wu, et al.
Medicine (2025) Vol. 104, Iss. 5, pp. e41379-e41379
Open Access | Times Cited: 2
A comprehensive overview of Artemisinin and its derivatives as anticancer agents
Zi-wei Zeng, Di Chen, Lei Chen, et al.
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115000-115000
Closed Access | Times Cited: 45
Zi-wei Zeng, Di Chen, Lei Chen, et al.
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115000-115000
Closed Access | Times Cited: 45
Progress in the Regulation of Immune Cells in the Tumor Microenvironment by Bioactive Compounds of Traditional Chinese Medicine
Yuqian Chen, Wenshuang Fan, Yanyan Zhao, et al.
Molecules (2024) Vol. 29, Iss. 10, pp. 2374-2374
Open Access | Times Cited: 10
Yuqian Chen, Wenshuang Fan, Yanyan Zhao, et al.
Molecules (2024) Vol. 29, Iss. 10, pp. 2374-2374
Open Access | Times Cited: 10
Dual-targeting of artesunate and chloroquine to tumor cells and tumor-associated macrophages by a biomimetic PLGA nanoparticle for colorectal cancer treatment
Jianqing Peng, Jia Zhou, Runbin Sun, et al.
International Journal of Biological Macromolecules (2023) Vol. 244, pp. 125163-125163
Closed Access | Times Cited: 21
Jianqing Peng, Jia Zhou, Runbin Sun, et al.
International Journal of Biological Macromolecules (2023) Vol. 244, pp. 125163-125163
Closed Access | Times Cited: 21
Artemisinin and Its Derivatives as Potential Anticancer Agents
L Y Wen, Ben Chung-Lap Chan, Ming‐Hua Qiu, et al.
Molecules (2024) Vol. 29, Iss. 16, pp. 3886-3886
Open Access | Times Cited: 7
L Y Wen, Ben Chung-Lap Chan, Ming‐Hua Qiu, et al.
Molecules (2024) Vol. 29, Iss. 16, pp. 3886-3886
Open Access | Times Cited: 7
Tumor-associated macrophages affect the treatment of lung cancer
Zhuchen Yu, Juntao Zou, Fei Xu
Heliyon (2024) Vol. 10, Iss. 7, pp. e29332-e29332
Open Access | Times Cited: 6
Zhuchen Yu, Juntao Zou, Fei Xu
Heliyon (2024) Vol. 10, Iss. 7, pp. e29332-e29332
Open Access | Times Cited: 6
Natural product/diet-based regulation of macrophage polarization: Implications in treatment of inflammatory-related diseases and cancer
Milad Ashrafizadeh, Amir Reza Aref, Gautam Sethi, et al.
The Journal of Nutritional Biochemistry (2024) Vol. 130, pp. 109647-109647
Closed Access | Times Cited: 6
Milad Ashrafizadeh, Amir Reza Aref, Gautam Sethi, et al.
The Journal of Nutritional Biochemistry (2024) Vol. 130, pp. 109647-109647
Closed Access | Times Cited: 6
Cucurbitacin B modulates M2 macrophage differentiation and attenuates osteosarcoma progression via PI3K /AKT pathway
Hong Wu, Tianjun Ma, Mei He, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 5, pp. 2215-2233
Closed Access | Times Cited: 5
Hong Wu, Tianjun Ma, Mei He, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 5, pp. 2215-2233
Closed Access | Times Cited: 5
Targeting regulated cell death: Apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity
Ziyu Guo, Yihuang Liu, Danyao Chen, et al.
Journal of Translational Internal Medicine (2025) Vol. 13, Iss. 1, pp. 10-32
Closed Access
Ziyu Guo, Yihuang Liu, Danyao Chen, et al.
Journal of Translational Internal Medicine (2025) Vol. 13, Iss. 1, pp. 10-32
Closed Access
Exploring Combinations of Dihydroartemisinin for Cancer Therapy: A Comprehensive Review
K. Usha Rani, Rohan Chand Sahu, Aiswarya Chaudhuri, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 765, pp. 151854-151854
Closed Access
K. Usha Rani, Rohan Chand Sahu, Aiswarya Chaudhuri, et al.
Biochemical and Biophysical Research Communications (2025) Vol. 765, pp. 151854-151854
Closed Access
Dihydroartemisinin alleviates diethylnitrosamine-induced hepatocarcinogenesis by targeting a novel MAZ/TRIM50 axis
Ruyuan Liu, Yuanyuan Huang, Di Li, et al.
International Immunopharmacology (2025) Vol. 156, pp. 114733-114733
Closed Access
Ruyuan Liu, Yuanyuan Huang, Di Li, et al.
International Immunopharmacology (2025) Vol. 156, pp. 114733-114733
Closed Access
Dihydroartemisinin inhibits tumor progress via blocking ROR1-induced STAT3-activation in non-small cell lung cancer
Yanping Li, Haoyi Sun, Caihong Bai, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112157-112157
Closed Access | Times Cited: 3
Yanping Li, Haoyi Sun, Caihong Bai, et al.
International Immunopharmacology (2024) Vol. 133, pp. 112157-112157
Closed Access | Times Cited: 3
Lessons learned from the discovery and development of the sesquiterpene lactones in cancer therapy and prevention
Israa Ahmad Cheikh, Chirine El‐Baba, Ali Youssef, et al.
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 12, pp. 1377-1405
Closed Access | Times Cited: 14
Israa Ahmad Cheikh, Chirine El‐Baba, Ali Youssef, et al.
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 12, pp. 1377-1405
Closed Access | Times Cited: 14
Transcription factor Fli-1 as a new target for antitumor drug development
Lanlan Li, Jia Yu, Sha Cheng, et al.
International Journal of Biological Macromolecules (2022) Vol. 209, pp. 1155-1168
Closed Access | Times Cited: 13
Lanlan Li, Jia Yu, Sha Cheng, et al.
International Journal of Biological Macromolecules (2022) Vol. 209, pp. 1155-1168
Closed Access | Times Cited: 13
Antitumour mechanisms of traditional Chinese medicine elicited by regulating tumour-associated macrophages in solid tumour microenvironments
Jiamin Gao, Weishan Tan, Luyun Yuan, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27220-e27220
Open Access | Times Cited: 2
Jiamin Gao, Weishan Tan, Luyun Yuan, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27220-e27220
Open Access | Times Cited: 2
Research advances on signaling pathways regulating the polarization of tumor-associated macrophages in lung cancer microenvironment
Wenqiang Li, Quan Yuan, Mei Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Wenqiang Li, Quan Yuan, Mei Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Natural products targeting macrophages in tumor microenvironment are a source of potential antitumor agents
Qiuping Liu, Yuying Chen, Pei An, et al.
Phytomedicine (2022) Vol. 109, pp. 154612-154612
Open Access | Times Cited: 10
Qiuping Liu, Yuying Chen, Pei An, et al.
Phytomedicine (2022) Vol. 109, pp. 154612-154612
Open Access | Times Cited: 10
Etiology of lipid-laden macrophages in the lung
Emily Stevenson, Ley Cody Smith, Mark Wilkinson, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110719-110719
Closed Access | Times Cited: 3
Emily Stevenson, Ley Cody Smith, Mark Wilkinson, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110719-110719
Closed Access | Times Cited: 3
Potential of Compounds Originating from the Nature to Act in Hepatocellular Carcinoma Therapy by Targeting the Tumor Immunosuppressive Microenvironment: A Review
Yunheng Li, Hui Li, Qiaojun He, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 195-195
Open Access | Times Cited: 4
Yunheng Li, Hui Li, Qiaojun He, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 195-195
Open Access | Times Cited: 4
Dihydroartemisinin breaks the immunosuppressive tumor niche during cisplatin treatment in Hepatocellular carcinoma
Yanguang Yang, Yuting Gao, Yi Gong, et al.
Acta Histochemica (2024) Vol. 126, Iss. 4, pp. 152171-152171
Closed Access
Yanguang Yang, Yuting Gao, Yi Gong, et al.
Acta Histochemica (2024) Vol. 126, Iss. 4, pp. 152171-152171
Closed Access
CASQ2 alleviates lung cancer by inhibiting M2 tumor‐associated macrophage polarization and JAK/STAT pathway
Yan Ding, Xiaoliang Yuan, Ying Wang, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 8
Closed Access
Yan Ding, Xiaoliang Yuan, Ying Wang, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 8
Closed Access
Dihydroartemisinin Inhibits Epithelial–Mesenchymal Transition Progression in Medullary Thyroid Carcinoma Through the Hippo Signaling Pathway Regulated by Interleukin-6
Ruicong Li, Xinyu Zhang, Yanan Ge, et al.
Cancer Biotherapy and Radiopharmaceuticals (2024)
Closed Access
Ruicong Li, Xinyu Zhang, Yanan Ge, et al.
Cancer Biotherapy and Radiopharmaceuticals (2024)
Closed Access
Dihydroartemisinin inhibits EMT progression in medullary thyroid carcinoma through Hippo signaling pathway regulated by IL-6
Ruicong Li, Xinyu Zhang, Yanan Ge, et al.
Research Square (Research Square) (2023)
Open Access
Ruicong Li, Xinyu Zhang, Yanan Ge, et al.
Research Square (Research Square) (2023)
Open Access
